20 articles
Clinical trial investigated whether pressurized oxygen treatments could stimulate new blood vessel growth in elderly participants.
New MRI technique measures heart oxygen efficiency in 3 minutes, potentially revolutionizing early heart disease detection.
A miniaturized PEMF device failed to raise SpO2 in healthy rats, suggesting COVID-19 benefits may be disease-specific.
A phase 2b trial finds allogeneic MSC infusions improved 6-minute walk distance by 63 meters vs placebo at 9 months in frail older adults.
Systematic review reveals hyperbaric oxygen therapy improved bone density and strength through multiple biological pathways in rats.
NO-primed extracellular vesicles transfer functional mitochondria to damaged kidney cells, restoring energy production and reducing injury.
Study shows intensive glucose management increases cardiac stem cells in heart attack patients, potentially improving recovery.
A terminated multicenter RCT examined whether mechanical cough assistance plus NIV could cut re-intubation rates in ICU patients with weak cough.
A novel class of ferroptosis inhibitors protects donor organs from ischemia-reperfusion injury, potentially saving thousands of transplant patients annually.
A sweeping review maps every known strategy for delivering therapies directly to mitochondria, from lifestyle habits to nanocarriers and gene editing.
Packaging mitochondria in erythrocyte-derived membranes dramatically improves delivery efficiency, pushing this experimental therapy closer to clinical reality.
Scientists review breakthrough methods for transferring healthy mitochondria into damaged cells to restore cellular energy and combat aging.
Austrian researchers tracked heart attack patients for 5 years after receiving bone marrow cell therapy to assess long-term cardiac outcomes.
A comprehensive review of pathophysiology, genetics, and emerging therapies for mitochondrial myopathies, spotlighting elamipretide and gene therapy.
A Phase 1/2 trial of NFS-02 gene therapy for LHON-associated vision loss was terminated before completion, raising questions about mitochondrial gene therapy.
65-patient trial tested bone marrow stem cells injected directly into damaged heart muscle to restore function in chronic heart failure.
A new review maps how blood stem cell metabolism shifts with aging and how leukemia hijacks those changes — pointing to targeted therapeutic strategies.
A 260-infant RCT tests whether adding bleomycin injections to low-dose propranolol accelerates hemangioma regression and improves skin outcomes.
Small trial tests autologous bronchial stem cells to repair damaged lung tissue in chronic obstructive pulmonary disease patients.
New research reveals how heart attacks trigger cascading damage and identifies promising combination therapies to protect the heart.
